Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

CVS and Walgreens announce opioid settlements totaling $10 billion

It could amount to the last round of huge settlements after years of litigation over the industry's role in an overdose crisis linked to more than 500,000 deaths in the U.S. over the past two decades.

WEKU

GSK Slips As Shingles Vaccine Drives Commanding Third-Quarter Beat

GSK stock jumped Wednesday after the company beat third-quarter forecasts due to strength from specialty medicines and Shingrix.

Investors Business Daily

How Novo Nordisk Is Trying To Lengthen Its Lead In Weight Loss Over Eli Lilly

Novo Nordisk is planning to boost production for weight-loss shot Wegovy as Eli Lilly angles for approval. NVO stock surged Wednesday.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

CVS, Walgreens reach $5 billion deals to settle opioid lawsuits

They are the two largest drugstore chains in the U.S.

Axios

How long can you test positive for Covid and when are you infectious?

A surge in cases is indicating a new wave has started in the UK

The Independent UK

Nine Covid symptoms affecting the fully vaccinated — and signs you may have it

Fainting and fatigue may signal onset of variant, experts say

The Independent UK

Estee Lauder Cuts Annual Forecasts as China Curbs Drag Demand

Estee Lauder Cos Inc cut its full-year sales and profit forecasts on Wednesday, signaling a hit to sales from persistent COVID-19-related lockdowns and store closures in major market China. The New York-based company's shares were down about 5% in premarket trade. Sales growth of many US companies like Estee has…

Asharq Al-Awsat

Read news from The Economist, FT, and more,
with one subscription

Who can get an autumn Covid booster jab and how do I book?

Booster vaccinations are being offered to everyone in England over the age of 50

The Independent UK

CVS Health agrees to $5B settlement of opioid lawsuits

CVS Health says it has agreed to pay about $5 billion to state, local and Native American tribal governments to settle lawsuits over the toll of opioids

The Independent UK

The WHO says monkeypox is still a global health emergency of concern, despite a 'promising' decline in cases

Despite a promising decline in global cases, the World Health Organization has determined that monkeypox should remain a "public health emergency of international concern". Here's why.

ABC News

The health care cost wars may be coming to a head

If they do, the political fallout will be defined by industry group brawling.

Axios

A Multi-National Mega Corp Trialled The 4-Day Work Week Got Great Results So Let’s Goooo

If even Unilever, of all companies, is allowing its staff a 4 day work week then we know that shit works.

Pedestrian.tv

CSL paying $312m to license mRNA vax tech

CSL Seqirus is paying $A312 million up-front to license next-generation mRNA technology from a small US company, Arcturus Therapeutics.

AAP

Cannabis Terpenes Reduce Inflammation, Says Gb Sciences Study

Gb Sciences, Inc. (OTCQB: GBLX), a leading plant-inspired, biopharmaceutical research and drug development company, co-published a study that demonstrates the potential of selected cannabinoids and terpenes to reduce inflammation.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Ketamine Could Soon Be A Treatment Option For This Rare Genetic Neurological Disorder

Specialty biopharma company PharmaTher Holdings Ltd. (OTCQB: PHRRF) has entered into an evaluation and exclusive option agreement with Case Western Reserve University (CWRU)

Benzinga

Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know

Editor's note: This story has been corrected to reflect that the FDA deferred action on Amicus Therapeutics' Biologics License Application.

StockNews.com

The Worst Biotech Stocks Investors Could Buy This Fall

Timber Pharmaceuticals (TMBR) recently received an NYSE warning for not meeting the minimum trading price requirement for quite some time. The stock has lost 84% year-to-date. Given the company’s weak fundamentals, the stock could be a poor choice for investors enticed by its negligible price. Let’s discuss….

AAP

Australian workers to trial four-day week

Consumer goods giant Unilever is expanding its four-day work week trial to Australia after impressive results in New Zealand.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Conversation

How coal miners and factory workers helped found the environmental movement

Rachel Carson, a scientist and writer from rural Pennsylvania, published Silent Spring 60 years ago. Many credit this book, which meticulously documented the damage that DDT pesticides were inflicting on wildlife, farm animals and people as early as the 1950s, with launching the modern environmental movement.

Investors Business Daily

Why IBD 50 Stock Harmony Biosciences Surged Well Above A Buy Zone

Harmony crushed third-quarter forecasts and unveiled promising results for its narcolepsy drug — leading the biotech stock to surge Tuesday.

Benzinga

The Three Pillars of Effective Ketamine Mental Health Treatment

By Kevin Nicholson, COO of Delic and CEO of Ketamine Wellness Centers

Benzinga

Psyched: Top Psychedelics Execs., 50% Of Americans Support Medical Psychedelics, Cary Grant's LSD Therapy & More

15 Global Psychedelics Executives To Keep An Eye On In 2022

The Walrus

Ask an Immunity Expert: What’s Next for COVID-19?

This pandemic can help us prepare for the next one, says Catherine Hankins, co-chair of Canada’s COVID-19 Immunity Task Force

Investors Business Daily

Blazing Hot Neurocrine Biosciences, With 40% Run This Year, Extends Breakout On Quarterly Beat

Neurocrine Biosciences beat third-quarter forecasts and raised its Ingrezza outlook for 2022, leading NBIX stock to jump Tuesday.

Investors Business Daily

Pfizer Hits Trifecta, Boosting Guidance After Quarterly Beat And Unveiling A Potential Win

Pfizer stock surged Tuesday after the company beat quarterly estimates, raised its outlook and announced respiratory vaccine data.

1 … 111 112 113 114

People

Tedros Adhanom Ghebreyesus

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

Food and Drug Administration

Michigan State University

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.